Study to Evaluate the Efficacy and Safety of Daily Oral TAK-875 25 and 50mg in Asia Pacific Adults With Type 2 Diabetes
Clinical trial NCT01647542 · TERMINATED
Trial details
- NCT number
- NCT01647542
- Sponsor
- Takeda
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2014-02-01
- Enrollment
- 393
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.